204 related articles for article (PubMed ID: 38278150)
21. Increased frequency of TIGIT
Brauneck F; Haag F; Woost R; Wildner N; Tolosa E; Rissiek A; Vohwinkel G; Wellbrock J; Bokemeyer C; Schulze Zur Wiesch J; Ackermann C; Fiedler W
Oncoimmunology; 2021 Jun; 10(1):1930391. PubMed ID: 34211801
[TBL] [Abstract][Full Text] [Related]
22. Mesenchymal stromal cells up-regulate CD39 and increase adenosine production to suppress activated T-lymphocytes.
Saldanha-Araujo F; Ferreira FI; Palma PV; Araujo AG; Queiroz RH; Covas DT; Zago MA; Panepucci RA
Stem Cell Res; 2011 Jul; 7(1):66-74. PubMed ID: 21546330
[TBL] [Abstract][Full Text] [Related]
23. Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function.
Renauer P; Park JJ; Bai M; Acosta A; Lee WH; Lin GH; Zhang Y; Dai X; Wang G; Errami Y; Wu T; Clark P; Ye L; Yang Q; Chen S
Cancer Immunol Res; 2023 Aug; 11(8):1068-1084. PubMed ID: 37253111
[TBL] [Abstract][Full Text] [Related]
24. Genetic and pharmacological targeting of A2a receptor improves function of anti-mesothelin CAR T cells.
Masoumi E; Jafarzadeh L; Mirzaei HR; Alishah K; Fallah-Mehrjardi K; Rostamian H; Khakpoor-Koosheh M; Meshkani R; Noorbakhsh F; Hadjati J
J Exp Clin Cancer Res; 2020 Mar; 39(1):49. PubMed ID: 32151275
[TBL] [Abstract][Full Text] [Related]
25. CD73 on T Cells Orchestrates Cardiac Wound Healing After Myocardial Infarction by Purinergic Metabolic Reprogramming.
Borg N; Alter C; Görldt N; Jacoby C; Ding Z; Steckel B; Quast C; Bönner F; Friebe D; Temme S; Flögel U; Schrader J
Circulation; 2017 Jul; 136(3):297-313. PubMed ID: 28432149
[TBL] [Abstract][Full Text] [Related]
26. Effect of ecto-5'-nucleotidase (eN) in astrocytes on adenosine and inosine formation.
Chu S; Xiong W; Parkinson FE
Purinergic Signal; 2014 Dec; 10(4):603-9. PubMed ID: 25129451
[TBL] [Abstract][Full Text] [Related]
27. Deleting SUV39H1 in CAR-T cells epigenetically enhances the antitumor function.
Wang Y; Zhao G; Wang S; Li N
MedComm (2020); 2024 May; 5(5):e552. PubMed ID: 38645666
[TBL] [Abstract][Full Text] [Related]
28. Generation of a Retargeted Oncolytic
Gentile C; Finizio A; Froechlich G; D'Alise AM; Cotugno G; Amiranda S; Nicosia A; Scarselli E; Zambrano N; Sasso E
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948316
[TBL] [Abstract][Full Text] [Related]
29. BLIMP1 and NR4A3 transcription factors reciprocally regulate antitumor CAR T cell stemness and exhaustion.
Jung IY; Narayan V; McDonald S; Rech AJ; Bartoszek R; Hong G; Davis MM; Xu J; Boesteanu AC; Barber-Rotenberg JS; Plesa G; Lacey SF; Jadlowsky JK; Siegel DL; Hammill DM; Cho-Park PF; Berger SL; Haas NB; Fraietta JA
Sci Transl Med; 2022 Nov; 14(670):eabn7336. PubMed ID: 36350986
[TBL] [Abstract][Full Text] [Related]
30. The effects of simulated ischemia on the levels of adenosine and its metabolites in slices of cerebellum, superior colliculus and hippocampus in the guinea pig-in vitro study.
Yamada T; Kobayashi T; Okada Y
Brain Res; 1998 Mar; 787(2):220-5. PubMed ID: 9518623
[TBL] [Abstract][Full Text] [Related]
31. Nucleoside-induced arteriolar constriction: a mast cell-dependent response.
Doyle MP; Linden J; Duling BR
Am J Physiol; 1994 May; 266(5 Pt 2):H2042-50. PubMed ID: 8203602
[TBL] [Abstract][Full Text] [Related]
32. Regnase-1 suppresses TCF-1+ precursor exhausted T-cell formation to limit CAR-T-cell responses against ALL.
Zheng W; Wei J; Zebley CC; Jones LL; Dhungana Y; Wang YD; Mavuluri J; Long L; Fan Y; Youngblood B; Chi H; Geiger TL
Blood; 2021 Jul; 138(2):122-135. PubMed ID: 33690816
[TBL] [Abstract][Full Text] [Related]
33. Comparison of elimination and cardiovascular effects of adenine nucleosides administered intrapericardially or intravenously in anesthetized dog.
Nagy A; Sax B; Entz L; Barát E; Toma I; Becker D; Merkely B; Kékesi V
J Cardiovasc Pharmacol; 2009 Oct; 54(4):341-7. PubMed ID: 19687746
[TBL] [Abstract][Full Text] [Related]
34. Phenotypic and functional characteristics of CD39
Figueiró F; Muller L; Funk S; Jackson EK; Battastini AM; Whiteside TL
Oncoimmunology; 2016 Feb; 5(2):e1082703. PubMed ID: 27057473
[TBL] [Abstract][Full Text] [Related]
35. B cells from Patients with Rheumatoid Arthritis Show Conserved CD39-Mediated Regulatory Function and increased CD39 Expression After Positive Response to Therapy.
Zacca ER; Amezcua Vesely MC; Ferrero PV; Acosta CDV; Ponce NE; Bossio SN; Mussano E; Onetti L; Cadile I; Acosta Rodríguez EV; Montes CL; Gruppi A
J Mol Biol; 2021 Jan; 433(1):166687. PubMed ID: 33098857
[TBL] [Abstract][Full Text] [Related]
36. CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy.
Giuffrida L; Sek K; Henderson MA; Lai J; Chen AXY; Meyran D; Todd KL; Petley EV; Mardiana S; Mølck C; Stewart GD; Solomon BJ; Parish IA; Neeson PJ; Harrison SJ; Kats LM; House IG; Darcy PK; Beavis PA
Nat Commun; 2021 May; 12(1):3236. PubMed ID: 34050151
[TBL] [Abstract][Full Text] [Related]
37. Absence epileptic activity changing effects of non-adenosine nucleoside inosine, guanosine and uridine in Wistar Albino Glaxo Rijswijk rats.
Kovács Z; Kékesi KA; Dobolyi Á; Lakatos R; Juhász G
Neuroscience; 2015 Aug; 300():593-608. PubMed ID: 26037802
[TBL] [Abstract][Full Text] [Related]
38. Preventing ATP Degradation by ASO-Mediated Knockdown of CD39 and CD73 Results in A2aR-Independent Rescue of T Cell Proliferation.
Festag J; Thelemann T; Schell M; Raith S; Michel S; Jaschinski F; Klar R
Mol Ther Nucleic Acids; 2020 Sep; 21():656-669. PubMed ID: 32739778
[TBL] [Abstract][Full Text] [Related]
39. Enhanced radiation-induced immunogenic cell death activates chimeric antigen receptor T cells by targeting CD39 against glioblastoma.
Sun T; Li Y; Yang Y; Liu B; Cao Y; Yang W
Cell Death Dis; 2022 Oct; 13(10):875. PubMed ID: 36245000
[TBL] [Abstract][Full Text] [Related]
40. CD26 CAR-T cells have attenuated mitochondrial and glycolytic metabolic profiling.
Zhu X; Zhong Z; Meng F; Zou P; You Y; Li Q; Zhu X
Immunopharmacol Immunotoxicol; 2023 Dec; 45(6):709-718. PubMed ID: 37382435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
